On the other hand, mutations that result in p53 inactivation are strongly associated with a more aggressive glioblastoma phenotype, with enhanced proliferative, migratory, and invasive capacity [130,132,133], as well as increased resistance to apoptosis and chemotherapy [134]. This evidence concerns the gene TP53 and glioblastoma.